#HVO hVIVO PLC – Positive data from novel human challenge models November 11, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces key insights from its scientific presentations at the 10th European Scientific Working Group on Influenza (“ESWI”) Conference in Valencia, and the World Vaccine Congress Europe in Amsterdam, which both took place in October 2025.   hVIVO presented positive data from a number of newly developed human challenge models reinforcing hVIVO’s continued world-leading capabilities in accelerating…

Continue reading

#POLB Poolbeg Pharma PLC – Conference Participation in March & April 2025 March 27, 2025 – Posted in: Uncategorized

27 March 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that CEO, Jeremy Skillington, will be participating in the following leading industry conferences in March and April 2025: Master Investor Show – Business Design Centre, London, UK Presentation details: 29 March, Showcase Stage (Ground Floor), 1.00pm – 1.10pm Poolbeg Pharma will be located at Booth M30. BioTrinity –…

Continue reading

#ELEG Electric Guitar PLC – Launch of Voco Solutions Portal at DMEXCO September 5, 2024 – Posted in: Electric Guitar Plc (ELEG)

Electric Guitar PLC (LSE: ELEG), the digital marketing and advertising company providing first-party data solutions, is pleased to announce that its primary operating subsidiary, 3radical Limited (“3radical”), will be officially launching its latest product, the Voco Solutions Portal (“VSP”), at the Digital Marketing Exposition & Conference (DMEXCO) in Cologne, Germany, on 18/19 September 2024.   VSP represents an evolution of 3radical’s established Voco platform, designed specifically to provide businesses with a streamlined and rapid deployment…

Continue reading